Injectable peptides after reconstitution typically require refrigeration
While BPC-157 shows no strong evidence of tolerance or receptor desensitization in most reports (unlike some growth hormone-releasing peptides), cycling is still utilized for safety, sustainability, and optimization
BPC 157 is a peptide originally derived from a protein in the stomach
The binding-induced conformational changes may facilitate the activation of G-proteins, which are signaling proteins hypothesized to be found on the intracellular side of the GHRH receptor
Scientists have studied this compound for experimental peptide analysis in laboratory settings
In animal research it has shown effects on the healing of skin, muscle, tendon and ligament, on angiogenesis, and on inflammation